Saniona
A rare disease biopharmaceutical company focused on research, development and commercialization of treatments for the central nervous system. Learn more
Launch date
Employees
Market cap
AUD97.9m
Enterprise valuation
AUD96m (Public information from Sep 2024)
Share price
SEK4.785 SANION.ST
Company register number 34049610
Ballerup Capital Region of Denmark (HQ)
Authorizing premium user...